KRAS and acute lymphoblastic leukemia: Analysis of the moribund recipients revealed that the thymus mass of Kras;Atg5−/− cell-derived recipients was significantly reduced compared with that of the Kras cell recipients, whereas the spleen and liver weights were comparable to those of Kras cell recipients (Fig. 7P), suggesting a less severe T-ALL.